Business Description
C-Mer Eye Care Holdings Ltd
ISIN : KYG2R51A1053
Share Class Description:
HKSE:03309: Ordinary SharesCompare
Compare
Traded in other countries / regions
03309.Hong Kong IPO Date
2018-01-15Description
C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include Sales of medical consumables, Mainland China ophthalmic business and Mainland China dental business. It generates a vast majority of its revenue from the provision of the ophthalmic services segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.54 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.2 | |||||
| Debt-to-EBITDA | 2.55 | |||||
| Interest Coverage | 6.6 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.93 | |||||
| Beneish M-Score | -2.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 34.2 | |||||
| 3-Year EBITDA Growth Rate | 36.4 | |||||
| 3-Year Book Growth Rate | 9.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.2 | |||||
| 9-Day RSI | 58.07 | |||||
| 14-Day RSI | 53.32 | |||||
| 6-1 Month Momentum % | -20.98 | |||||
| 12-1 Month Momentum % | -30.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.85 | |||||
| Quick Ratio | 1.75 | |||||
| Cash Ratio | 1.43 | |||||
| Days Inventory | 11.91 | |||||
| Days Sales Outstanding | 9.42 | |||||
| Days Payable | 14.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.1 | |||||
| Shareholder Yield % | 3.58 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.17 | |||||
| Operating Margin % | 6.22 | |||||
| Net Margin % | 3.22 | |||||
| FCF Margin % | 12.75 | |||||
| ROE % | 3.35 | |||||
| ROA % | 2.23 | |||||
| ROIC % | 3.67 | |||||
| ROC (Joel Greenblatt) % | 19.53 | |||||
| ROCE % | 6.06 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 59.4 | |||||
| PE Ratio without NRI | 58.24 | |||||
| Shiller PE Ratio | 99 | |||||
| Price-to-Owner-Earnings | 15.57 | |||||
| PEG Ratio | 2.34 | |||||
| PS Ratio | 1.92 | |||||
| PB Ratio | 2.02 | |||||
| Price-to-Tangible-Book | 4.95 | |||||
| Price-to-Free-Cash-Flow | 15.07 | |||||
| Price-to-Operating-Cash-Flow | 10.23 | |||||
| EV-to-EBIT | 24.29 | |||||
| EV-to-EBITDA | 24.29 | |||||
| EV-to-Revenue | 1.8 | |||||
| EV-to-FCF | 13.8 | |||||
| Price-to-Projected-FCF | 1.98 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.34 | |||||
| Price-to-Graham-Number | 3.58 | |||||
| Earnings Yield (Greenblatt) % | 4.12 | |||||
| FCF Yield % | 6.58 | |||||
| Forward Rate of Return (Yacktman) % | 20.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
C-Mer Eye Care Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,923.964 | ||
| EPS (TTM) (HK$) | 0.05 | ||
| Beta | 1.05 | ||
| Volatility % | 34.34 | ||
| 14-Day RSI | 53.32 | ||
| 14-Day ATR (HK$) | 0.100328 | ||
| 20-Day SMA (HK$) | 2.8335 | ||
| 12-1 Month Momentum % | -30.79 | ||
| 52-Week Range (HK$) | 2.39 - 4.5 | ||
| Shares Outstanding (Mil) | 1,255.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
C-Mer Eye Care Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
C-Mer Eye Care Holdings Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
C-Mer Eye Care Holdings Ltd Frequently Asked Questions
What is C-Mer Eye Care Holdings Ltd(HKSE:03309)'s stock price today?
The current price of HKSE:03309 is HK$2.97. The 52 week high of HKSE:03309 is HK$4.50 and 52 week low is HK$2.39.
When is next earnings date of C-Mer Eye Care Holdings Ltd(HKSE:03309)?
The next earnings date of C-Mer Eye Care Holdings Ltd(HKSE:03309) is .
Does C-Mer Eye Care Holdings Ltd(HKSE:03309) pay dividends? If so, how much?
C-Mer Eye Care Holdings Ltd(HKSE:03309) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers